FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

7 letters match. Newest first.

  1. MONQ, LLC

    MONQ sold unapproved inhalation essential oil products with claims to treat opioid addiction and withdrawal, FDA and FTC said.

    High risk
  2. Eagle Energy USA, Inc.

    FDA warned Eagle Energy USA that its inhalable Caffeine Pen products are unapproved new drugs with safety concerns.

    High risk
  3. VitaStik, Inc.

    FDA warned VitaStik that its oral inhalation sticks are unapproved new drugs marketed with claims to treat asthma, anxiety, sleep and other conditions.

    High risk
  4. VitaCig, Inc.

    FDA warned VitaCig that its flavored inhalers and capsules are unapproved new drugs sold with disease-treatment claims on its website.

    High risk
  5. NV Nutrition, LLC

    FDA warned NV Nutrition that its inhalable vaporizer and diffuser products are drugs sold without FDA approval and promoted with disease claims.

    High risk
  6. Vitamin Vape, Inc.

    FDA says Vitamin Vape sold B12 VitaminVape as a drug without FDA approval and made drug claims online.

    High risk
  7. Evolved Ayurvedic Discoveries, Inc./BioCBDPlus

    FDA warned BioCBDPlus that its CBD topicals and vape are unapproved new drugs sold with disease and COVID-19 claims.

    High risk